REPORT ID 460

Global Contract Pharmaceutical Manufacturing Market Professional Survey Report 2017

Publish Date
01-Dec-17
Pages
112
Format
Electronic (PDF)

This report studies Contract Pharmaceutical Manufacturing in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Catalent
    DPx
    Lonza
    Piramal Healthcare
    Aenova
    Jubilant
    Famar
    Boehringer Ingelheim
    Fareva Holding
    AbbVie
    Nipro Corp
    Vetter
    Sopharma
    DPT Laboratories
    Recipharm
    NextPharma
    Dishman
    Aesica

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Active Pharmaceutical Ingredients (API)
    Finished Dosage Formulations (FDF)

By Application, the market can be split into
    Big Pharma
    Specialty/Midsize
    Generics
    Other

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Contract Pharmaceutical Manufacturing Market Professional Survey Report 2017
1 Industry Overview of Contract Pharmaceutical Manufacturing
    1.1 Definition and Specifications of Contract Pharmaceutical Manufacturing
        1.1.1 Definition of Contract Pharmaceutical Manufacturing
        1.1.2 Specifications of Contract Pharmaceutical Manufacturing
    1.2 Classification of Contract Pharmaceutical Manufacturing
        1.2.1 Active Pharmaceutical Ingredients (API)
        1.2.2 Finished Dosage Formulations (FDF)
    1.3 Applications of Contract Pharmaceutical Manufacturing
        1.3.1 Big Pharma
        1.3.2 Specialty/Midsize
        1.3.3 Generics
        1.3.4 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Contract Pharmaceutical Manufacturing
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Contract Pharmaceutical Manufacturing
    2.3 Manufacturing Process Analysis of Contract Pharmaceutical Manufacturing
    2.4 Industry Chain Structure of Contract Pharmaceutical Manufacturing

3 Technical Data and Manufacturing Plants Analysis of Contract Pharmaceutical Manufacturing
    3.1 Capacity and Commercial Production Date of Global Contract Pharmaceutical Manufacturing Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Contract Pharmaceutical Manufacturing Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Contract Pharmaceutical Manufacturing Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Contract Pharmaceutical Manufacturing Major Manufacturers in 2016

4 Global Contract Pharmaceutical Manufacturing Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Contract Pharmaceutical Manufacturing Capacity and Growth Rate Analysis
        4.2.2 2016 Contract Pharmaceutical Manufacturing Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Contract Pharmaceutical Manufacturing Sales and Growth Rate Analysis
        4.3.2 2016 Contract Pharmaceutical Manufacturing Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Contract Pharmaceutical Manufacturing Sales Price
        4.4.2 2016 Contract Pharmaceutical Manufacturing Sales Price Analysis (Company Segment)

5 Contract Pharmaceutical Manufacturing Regional Market Analysis
    5.1 North America Contract Pharmaceutical Manufacturing Market Analysis
        5.1.1 North America Contract Pharmaceutical Manufacturing Market Overview
        5.1.2 North America 2012-2017E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.1.4 North America 2016 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.2 China Contract Pharmaceutical Manufacturing Market Analysis
        5.2.1 China Contract Pharmaceutical Manufacturing Market Overview
        5.2.2 China 2012-2017E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.2.4 China 2016 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.3 Europe Contract Pharmaceutical Manufacturing Market Analysis
        5.3.1 Europe Contract Pharmaceutical Manufacturing Market Overview
        5.3.2 Europe 2012-2017E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.3.4 Europe 2016 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.4 Southeast Asia Contract Pharmaceutical Manufacturing Market Analysis
        5.4.1 Southeast Asia Contract Pharmaceutical Manufacturing Market Overview
        5.4.2 Southeast Asia 2012-2017E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.4.4 Southeast Asia 2016 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.5 Japan Contract Pharmaceutical Manufacturing Market Analysis
        5.5.1 Japan Contract Pharmaceutical Manufacturing Market Overview
        5.5.2 Japan 2012-2017E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.5.4 Japan 2016 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.6 India Contract Pharmaceutical Manufacturing Market Analysis
        5.6.1 India Contract Pharmaceutical Manufacturing Market Overview
        5.6.2 India 2012-2017E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.6.4 India 2016 Contract Pharmaceutical Manufacturing Market Share Analysis

6 Global 2012-2017E Contract Pharmaceutical Manufacturing Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Contract Pharmaceutical Manufacturing Sales by Type
    6.2 Different Types of Contract Pharmaceutical Manufacturing Product Interview Price Analysis
    6.3 Different Types of Contract Pharmaceutical Manufacturing Product Driving Factors Analysis
        6.3.1 Active Pharmaceutical Ingredients (API) of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis
        6.3.2 Finished Dosage Formulations (FDF) of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis

7 Global 2012-2017E Contract Pharmaceutical Manufacturing Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Contract Pharmaceutical Manufacturing Consumption by Application
    7.2 Different Application of Contract Pharmaceutical Manufacturing Product Interview Price Analysis
    7.3 Different Application of Contract Pharmaceutical Manufacturing Product Driving Factors Analysis
        7.3.1 Big Pharma of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis
        7.3.2 Specialty/Midsize of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis
        7.3.3 Generics of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis
        7.3.4 Other of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Contract Pharmaceutical Manufacturing
    8.1 Catalent
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Catalent 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Catalent 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.2 DPx
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 DPx 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 DPx 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.3 Lonza
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Lonza 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Lonza 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.4 Piramal Healthcare
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Piramal Healthcare 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Piramal Healthcare 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.5 Aenova
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Aenova 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Aenova 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.6 Jubilant
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Jubilant 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Jubilant 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.7 Famar
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Famar 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Famar 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.8 Boehringer Ingelheim
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Boehringer Ingelheim 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Boehringer Ingelheim 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.9 Fareva Holding
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Fareva Holding 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Fareva Holding 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.10 AbbVie
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 AbbVie 2016 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 AbbVie 2016 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.11 Nipro Corp
    8.12 Vetter
    8.13 Sopharma
    8.14 DPT Laboratories
    8.15 Recipharm
    8.16 NextPharma
    8.17 Dishman
    8.18 Aesica

9 Development Trend of Analysis of Contract Pharmaceutical Manufacturing Market
    9.1 Global Contract Pharmaceutical Manufacturing Market Trend Analysis
        9.1.1 Global 2017-2022 Contract Pharmaceutical Manufacturing Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Contract Pharmaceutical Manufacturing Sales Price Forecast
    9.2 Contract Pharmaceutical Manufacturing Regional Market Trend
        9.2.1 North America 2017-2022 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.2 China 2017-2022 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.3 Europe 2017-2022 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.5 Japan 2017-2022 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.6 India 2017-2022 Contract Pharmaceutical Manufacturing Consumption Forecast
    9.3 Contract Pharmaceutical Manufacturing Market Trend (Product Type)
    9.4 Contract Pharmaceutical Manufacturing Market Trend (Application)

10 Contract Pharmaceutical Manufacturing Marketing Type Analysis
    10.1 Contract Pharmaceutical Manufacturing Regional Marketing Type Analysis
    10.2 Contract Pharmaceutical Manufacturing International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Contract Pharmaceutical Manufacturing by Region
    10.4 Contract Pharmaceutical Manufacturing Supply Chain Analysis

11 Consumers Analysis of Contract Pharmaceutical Manufacturing
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Contract Pharmaceutical Manufacturing Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source